chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she is having a hard time sleeping; swelling; She developed a knot on the side of her neck that was very painful; She does not know if it is a swollen lymph node; right arm pain; pain started traveling up her neck to the shoulder area.; pain started traveling up her neck to the shoulder area; This is a spontaneous report from a contactable consumer (patient). A 29-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EH9899), intramuscular on 24Dec2020 08:30 at the first single dose for covid-19 immunisation.  Medical history reported as none. There were no concomitant medications. The patient received vaccine in Right arm. She got the Pfizer Covid19 vaccine on 24Dec2020. The right arm pain started two hours after getting the vaccine and the arm pain got progressively worse and the pain started traveling up her neck to the shoulder area on 24Dec2020. The patient experiencing Right neck pain and swelling on 26Dec2020. She developed a knot on the side of her neck that was very painful, along with arm pain that went up to her neck on 26Dec2020. The knot developed about 2 days after she got the vaccine and now the knot is getting larger. She does not know if it is a swollen lymph node but she has never had a swollen lymph node in that area, states it is above her collar bone and the knot is very painful. She is thinking to go to urgent care since it is bothering her to where she is having a hard time sleeping. On 26Dec2020 she noticed it was painful in the particular spot where she found the knot. Her arm pain went away by the 27Dec2020 and it was not too painful any more, she clarifies her arm pain recovered completely as of 27Dec2020. The painful knot has gotten worse. The patient did not receive any treatment for the events. The outcome of event right arm pain was recovered on 27Dec2020; outcome of event knot on the side of her neck was not recovered; outcome of other events was unknown.
pt recv vax 4MAR96 & 4 days post vax pt exp petechial bruising, particularly on arms & legs;MD visit was required;sx cont;pt did not receive any other vaccines 4MAR96;
lightheadedness and syncopal episode.  States "all of the sudden he felt hot and passed out"  He was hypotensive with b/p 75/51 HR 65.  EKG NSR.  sent to the ER for further evaluation.
Information has been received from a registered nurse referring to an unknown number of patients. On unspecified dates the patients were vaccinated with doses of ROTATEQ (dose, lot number and expiry date not reported) orally that had been improperly stored. No adverse effects reported. This one of several reports received from the same reporter. Additional information is not expected as the reporter did not wish to be contacted.
Initial report was received from a patient on 25 October 2011. A 43-year-old female patient had received an intramuscular (IM) injection of FLUZONE in left deltoid; lot number UT481AB on 27 September 2011. On the same day, immediately after the vaccination the patient developed soreness in her arm which has gotten increasingly worse, sharp pain with certain movements, limited range of motion (ROM) and feels a "soft burn in her muscle". No further information was available at the time of the report. The patient's outcome was not recovered/not resolved. Documents held by sender: none.
I broke out in hives on my neck and chest and down my right arm. I did not get them on the arm I got the vaccine.; This is a spontaneous report received from a 64-year-old female contactable consumer reported for herself. A 64-year-old non-pregnant female patient received unknown dose of bnt162b2 (Pfizer covid-19 vaccine, Solution for injection, Batch/Lot number: Unknown), via an unspecified route in the left arm on 19Mar2021 at 10:15 (age at vaccination: 64-year-old) as a single dose for covid-19 immunization. Medical history was reported as none. The patient concomitant medications were not reported. No known allergies to medications, food, or other products were reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. On an unknown date, patient broke out in hives on her neck and chest and down her right arm. Patient did not get them on the arm she got the vaccine. Therapeutic measures taken as a result of the events included Prednisone. Adverse events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
this effect is similar to Guillain-Barre syndrome; Pain at the site for 2 to 3 days off and on; Loose bowels; minor stomach cramps; Cold sweat; Chills; Tingling all over my hands, my body but mostly my hands 1000's of needle pricks, that is the effect; Shaking; Could not move; Cramps in legs; This is a spontaneous report from a contactable consumer, the patient. An unspecified patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: FC3180, expiration date: 01Oct2021), via an unspecified route of administration, on an unspecified date, as single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient stated that, patient wanted to report a side effect. There was pain at the site for 2 to 3 days off and on, loose bowels, minor stomach cramps. About on the 4th day patient was woken up, about 4 in the morning, cold sweat, chills, tingling all over hands, patient's body but mostly patient's hands 1000's of needle pricks, that was the effect. Patient was shaking. Patient could not move, Patient had cramps in legs and this lasted 3 hours. If Patient had been driving a car when this happened, patient did not know if patient could operate the car. Patient further stated, from what I understood, it was not a good idea for me to have a second shot, this effect was similar to Guillain-Barre syndrome. Outcome of the event cramps in legs was recovered on an unknown date and outcome of the rest events was unknown.  No follow-up attempts are needed. No further information is expected.
RIGHT LATERAL THIGH W/ INDURATION, REDNESS, WARM TO TOUCH AND TENDER.  SYMPTOMS FIRST NOTICED 8/2/10 IN AM, SITE INCREASED IN SIZE FRP, NICKEL SIZE IN AM TO APPROX 3 INCHES DIAMETER.  TREATEMENT:  RX ORAPRED, BENADRYL, BACTRIM
itching/ itching on her face, arms, head/ itching in her scalp, ears, head, face, neck and a little bit in my arms and legs; itching/ itching on her face, arms, head/ itching in her scalp, ears, head, face, neck and a little bit in my arms and legs; This is a spontaneous report from a contactable consumer (patient herself). A 69-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL9262, Expiration date: Unknown, NDC number: Unknown), intramuscularly in left arm on 26Jan2021 14:00 at single dose for COVID-19 immunisation in clinic. The patient's medical history included thyroid issues, back issues, she had done some reading and she has allergies to some antibiotics, one of them being sulfa, allergic to bicillins, she has a whole host of antibiotic allergies which she investigated prior to receiving the vaccine and she was told it wasn't an issue. Concomitant medications were none. The patient previously took azithromycin (ZITHROMAX), levofloxacin (LEVAQUIN), omeprazole (PRILOSEC), levothyroxine and experienced allergy to all drugs. The patient did not receive prior vaccinations (within 4 weeks). The patient did not administer additional vaccines on same date of the Pfizer suspect. It was reported that the caller received her COVID-19 vaccine yesterday at 14:00. She had no problems at all. She was feeling some itching on her face, arms, head on 28Jan2021. She was wanting to know was there any kind of sulfa product in the COVID-19 vaccine. Caller confirms she had no problems at all with the administration of the vaccine. She didn't feel a thing. It was very organized. The caller states the itching began about an hour ago on 28Jan2021. Caller clarifies she actually received her first vaccine on 26Jan2021 14:00. On her vaccine record card, she sees EL and the third digit was either a 9 or 4. She was able to look at her husband's vaccine card and it looks like a different person wrote on his and she sees "EL9262" on his card so she assumes that was what was written on hers. Caller explains she has thyroid issues and back issues, but she considers herself to be in pretty decent health. Caller states she received her first Pfizer vaccine dose 2 days ago and today around 5 pm started itching in her scalp, ears, head, face, neck and a little bit in my arms and legs. No rash. Allergic to sulfa, also allergic to "the cillins", caller states she did her research before she got the vaccine. "Enquired was there any sulfa in the vaccine or not." No investigation assessment. The patient did not require a visit to emergency room and physician office. No relevant tests. The outcome of the events was unknown.
Patient experienced pain at injection site with swelling and tingling in fingers. Patient went to see neurologist and has experienced nerve damage due to injection.
COLD; BODY ACHES EVERYWHERE; HARD TO SLEEP; SHIVERING; FEVER; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was feeling normal all day until fever comes. The patient took some medicine and cat was purring and cuddling with patient in bed. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 03-JAN-2022 for prophylactic vaccination. The batch number was not reported. The company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 03-JAN-2022, the patient experienced cold, body aches everywhere, hard to sleep, shivering, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, cold, body aches everywhere, hard to sleep and shivering was not reported. This report was non-serious.
It was reported that a male pt received a TD vax on 4/7/99 and reportedly, the TD was administered in the pt's left deltoid. The pt developed brachial plexitis on left side. The pt was seen by a neurologist, who confirmed the dx.
wheezing, dizziness, lightheadedness, fatigue, GI distress, hoarseness, Stridor, muscle/joint aches, skin redness/rash, nausea, vomiting, flushed skin, blurred vision
Patient had not received any previous Covid vaccine doses and was indicated to receive the Dark Blue Cap Moderna Bivalent Vaccine (25mcg). The Dark Pink Cap Moderna Bivalent Vaccine (10 mcg) was administered by the Medical Assistant instead of the Dark Blue Cap Moderna Bivalent Vaccine.  RN Lead of clinic reached out to Vaccine Coordinator,  for clarification on next dose due to incorrect initial dose. No adverse events related to incident. Incident reported on both database and VAERS. Will contact parent to inform parent of plan of care once feedback is received from Vaccine Coordinator.
(L) arm swollen, erythematous with small blisters somewath tender. Yesterday he had two small, linear vesiculations. Now there are four new linear vesiculation.
12 year old inadvertently given Moderna vaccine; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old inadvertently given Moderna vaccine) in a 12-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 049L21A) for COVID-19 vaccination.     No any allergic condition was reported. No medical history was provided.     On 23-May-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 23-May-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old inadvertently given Moderna vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (12 year old inadvertently given Moderna vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2021, SARS-CoV-2 test: positive (Positive) Positive, no hospitalization; no medications taken.         It was reported that the vaccine provider informed to patient family and told them that patient can be given the Pfizer vaccine in 6-8 weeks.  Concomitant product use was not provided by the reporter.  No treatment information was provided.  The patient mother wants to get a 2nd opinion on how to go about the situation. It was reported that except for the soreness at the site of the injection (right arm) as a result of this misadministration.
Coughing, sore throat, fever, congestion, malaise, slight shortness of breath
Developed intussusception. Seen for anal fissure 4-7-11, well child exam with vaccines 4-8-11. Seen for blood in stools, diarrhea, vomiting. Was not eating well 4-9-11. To ER and admitted for same 4-10-11.
Chest pain and joint pain . The pain in my chest began about 45 minutes after receiving the vaccine. I had a fever of 102 F the next day, that lasted 24 hours. I had joint pain. I have been diagnosed with chest wall pain in the past and the inflammation in my chest was similar and brought on directly after receiving the vaccine.  I had had had an episode of chest pain within the months before the vaccine. I rarely get it and the history goes back 20 years.
itching of face and neck, hives on neck. b/p 143/94 asked to take oral benadryl and tylenol tonight and f/u with pcp if sx persist
11/05/22 presents to ED for "altered mental status, and corona virus concern". PMHx of "HTN and anxiety"
This spontaneous report as received from a Licensed Vocational Nurse regarding 9 patients of unknown demographics. There was no information about pertinent medical history, drug reactions or drug allergies. On 23-JUN-2015, the patient were vaccinated with improperly stored dose of VARIVAX (Merck) lot# K021484 and expiry date: 03-NOV-2016. No adverse effect was reported. The outcome of the event was unknown. This is one of the several reports from the same reporter. Additional information has been requested.
it's going down the inside of the arm now; it started to itch in that area; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (it's going down the inside of the arm now) and VACCINATION SITE PRURITUS (it started to itch in that area) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced PRURITUS (it's going down the inside of the arm now) and VACCINATION SITE PRURITUS (it started to itch in that area). At the time of the report, PRURITUS (it's going down the inside of the arm now) and VACCINATION SITE PRURITUS (it started to itch in that area) outcome was unknown.            Treatment and concomitant medications were not reported. Action taken in response to mRNA-1273 was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 17-Feb-2021: process with initial
Information has been received from a nurse concerning a female patient who in 2007 was vaccinated with a dose of GARDASIL. The patient fainted after administration of HPV vaccine and was observed for thirty minutes. Medical attention was sought by an office visit. The patient recovered from syncope. This is one of two reports received from the same source. Additional information has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (milder reaction to the 1st booster dose) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058F21A, 058F21A and 010M20A) for COVID-19 vaccination. Concurrent medical conditions included Ulcerative colitis. Concomitant products included MESALAZINE (APRISO) for Ulcerative colitis, SIMVASTATIN and CALAMINE for an unknown indication. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Nov-2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (milder reaction to the 1st booster dose). At the time of the report, VACCINATION COMPLICATION (milder reaction to the 1st booster dose) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient height was reported as 5'2". Treatment details was not reported by the reporter. This case was linked to MOD-2021-019539, MOD-2022-535387 (Patient Link).
Information has been received from a medical assistant, concerning a 24 year old patient of unknown gender. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medication were not reported. On 23-APR-2018, the patient was vaccinated with a first expired dose of the series VAQTA 50U/1ml injection, lot number N005605 with expiration date on 08-APR-2018 (route of administration and anatomical location were not provided), for prophylaxis. No prior excursion and no adverse effects were reported.
Fatigue around 10 hours after initial vaccination. Radiating ache and joint pain from the injection site. After 12 hours, temperature reached 99.7 F.  At 14 hours after vaccination, major aches and soreness, chills and fever rose to 101.2. By 1:00am fever had reached 103.0F (all temperatures taken with ear thermometer). I took 1000mg of Tylenol at that time, which greatly reduced the aches and pains. Woke up with a temp of 99.2, minor aches, almost all effects had subsided.
Received shot 12/11/2015. Month earlier flu shot. 2 hrs later home diarrhea, hives, fever; Next day site of injection got inflamed and larger. Urgent care - 12/19. TYLENOL fever BENADRYL.
a dose of RECOMBIVAX HB was given today wilh a dose of PEDIARIX; This spontaneous report was received from a registered nurse concerning a 2 months old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided.           On 24-SEP-2020, the patient was vaccinated with a dose of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) with a dose of diphtheria toxoid (+) hepatitis B virus vaccine rHBsAg (yeast) (+) pertussis acellular 3-component vaccine (+) poliovirus vaccine inactivated (Vero) (+) tetanus toxoid  (PEDIARIX) (strength, dose, route, lot# and expiration date were not provided for any suspect therapies) for prophylaxis.
A report was received from a health professional on 10/12/01, concerning a 53 year old female patient who experienced an injection site reaction after receiving Fluvirin vaccine on 10/04/01. The patient had previously received an Influenza vaccination on 11/18/99 (Batch number 60065AA). The patient received 0.5 mg IM, in the left arm on 10/04/01. The patient developed erythema with a central yellowish clearing. There was not pain or tenderness and no warmth or sign of infection. The patient was treated with warm compresses and Benadryl every 4 to 6 hours. The arm was rechecked on 10/11/01 and the skin tone was normal and the arm was getting better. At the time of the report, the patient was rescheduled in 1 week. There was insufficient information to determine the reporter's causality assessment.
chest pain, shortness of breath.  Occurred within 48 hours of injection. Lasted 7 days.
Bedridden; Redness; Swelling; This case was reported by a nurse via call center representative and described the occurrence of bedridden in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced bedridden, erythema and swelling. On an unknown date, the outcome of the bedridden, erythema and swelling were unknown.   It was unknown if the reporter considered the bedridden, erythema and swelling to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not applicable for this report. The age group was not reported but was selected as adult as per vaccine indication. A nurse reports that approximately 15 to 20 percent of patients who were injected with Shingrix ended up bedridden with unspecified side effects.  The reporter did mention redness and swelling but was not specific if there were injection site reactions.  The reporter consented to follow up.
Chest pains; Trouble breathing; Heart keeps racing; Pregnant; This spontaneous prospective pregnancy case was reported by an other health care professional and describes the occurrence of CHEST PAIN (Chest pains), DYSPNOEA (Trouble breathing), PALPITATIONS (Heart keeps racing) and MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced CHEST PAIN (Chest pains), DYSPNOEA (Trouble breathing), PALPITATIONS (Heart keeps racing) and MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). At the time of the report, CHEST PAIN (Chest pains), DYSPNOEA (Trouble breathing) and PALPITATIONS (Heart keeps racing) outcome was unknown and MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication and treatment information was not reported by the reporter.
Symptoms started 4/1/23. She was ok but came home early that evening due to fatigue. On 4/2/23, she had swollen lymph nodes, body aches, eyes hurt, nausea, headache, vomiting. Mom treated at home with cold compresses, Tylenol and Advil. On 4/3/23, migraine headache intensified, and she started getting itchy toes. On 4/4/23, hives developed over body.  Mom brought her in to the clinic and a shot was given with Dexamethasone 4 mg mixed with Depo-Medrol 40 mg IM.
Information has been received from a registered nurse concerning a 17 year old female who on 06/09/1999 and on 08/30/2000 was vaccinated with a first and second dose of hepatitis A virus vaccine inactivated.  It was reported that one or both of the vaccinations was from a recalled lot.  Serology testing performed on 09/09/2002 showed her hepatitis A immunity status was determined to be "borderline."  The patient sought unspecified medical attention.  Follow-up information received on 02/20/2003 from a doctor of pharmacy reported that "they do not know who the patient is."  Lot numbers were not available.  No further information is expected.